third quarter
GSK’s Vaccine Sales Plummet in Q3, Highlighting Reduced Demand and Market Challenges
GSK, vaccine sales, third quarter, reduced demand, Arexvy, Shingrix, influenza vaccine
Actionable Insights Powered by AI
GSK, vaccine sales, third quarter, reduced demand, Arexvy, Shingrix, influenza vaccine